volume 40, issue 3, P277-282 2012
DOI: 10.1016/j.jcms.2011.04.011
View full text
Julia S. Bauer, Nina Beck, Julia Kiefer, Philipp Stockmann, Manfred Wichmann, Stephan Eitner

Abstract: The level of information is poor concerning the side effects of bisphosphonates, particularly the risk of BONJ. Clinicians should aim to sensitize the relevant people about the risks before treatment.